Literature DB >> 11020176

Applications of fast-setting hydroxyapatite cement: cranioplasty.

P D Costantino1, J M Chaplin, M E Wolpoe, P J Catalano, C Sen, J B Bederson, S Govindaraj.   

Abstract

A variety of autogenous and synthetic materials have been used to repair cranial defects resulting from traumatic and iatrogenic causes. In theory, the ideal material should be readily available and safe. It should adequately protect the underlying central nervous system, resist cerebrospinal fluid fistula formation, and be easily contoured. One promising synthetic biomaterial that has been used for cranioplasty is hydroxyapatite cement. This biomaterial has successfully restored cranial contour in most patients in whom it has been used; however, difficulties have arisen because of the material's prolonged water solubility. When exposed to cerebrospinal fluid or blood, inadequate setting of the cement occurs, resulting in loss of its structural integrity. This problem can be alleviated with the use of fast-setting hydroxyapatite cement, which hardens 6 to 12 times faster than the traditional cement. We present, to the best of our knowledge, the first series of the use of this material in 21 patients requiring cranioplasty. The advantages and limitations of fast-setting hydroxyapatite cement will be discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11020176     DOI: 10.1067/mhn.2000.107679

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  13 in total

1.  [Custom moldable hydroxyapatite collagen composite for repair of osseous defects].

Authors:  R Mai; A Reinsdorf; E Pilling; G Lauer; M Gelinsky; U Eckelt
Journal:  Mund Kiefer Gesichtschir       Date:  2005-01

Review 2.  A review of reconstructive materials for use in craniofacial surgery bone fixation materials, bone substitutes, and distractors.

Authors:  James Tait Goodrich; Adam L Sandler; Oren Tepper
Journal:  Childs Nerv Syst       Date:  2012-08-08       Impact factor: 1.475

3.  Cranioplasties following craniectomies in children-a multicenter, retrospective cohort study.

Authors:  Vita M Klieverik; Kai J Miller; Kuo Sen Han; Ash Singhal; Michael Vassilyadi; Charles J Touchette; Alexander G Weil; Peter A Woerdeman
Journal:  Childs Nerv Syst       Date:  2018-12-15       Impact factor: 1.475

Review 4.  Cranioplasty after craniectomy in pediatric patients-a systematic review.

Authors:  Vita M Klieverik; Kai J Miller; Ash Singhal; Kuo Sen Han; Peter A Woerdeman
Journal:  Childs Nerv Syst       Date:  2019-01-04       Impact factor: 1.475

5.  Vascularized mastoid bone flap cranioplasty after translabyrinthine vestibular schwannoma surgery.

Authors:  Heng-Wai Yuen; Andrew L Thompson; Sean P Symons; Farhad Pirouzmand; Joseph M Chen
Journal:  Skull Base       Date:  2009-05

6.  Porous CaP/silk composite scaffolds to repair femur defects in an osteoporotic model.

Authors:  Ning Cheng; Jing Dai; Xiangrong Cheng; Shu'e Li; Richard J Miron; Tao Wu; Wenli Chen; Yufeng Zhang; Bin Shi
Journal:  J Mater Sci Mater Med       Date:  2013-05-15       Impact factor: 3.896

7.  Reconstruction of Skull Base and Fronto-orbital Defects following Tumor Resection.

Authors:  Kurt Laedrach; Anton Lukes; Joram Raveh
Journal:  Skull Base       Date:  2007-02

8.  [Efficacy of inactivated autologous porous bone flap and BAM bone-induced artificial bone for repairing skull defect in rats].

Authors:  Chao-Min Wang; Tie-Jian Liu; Zhen-Hua Song; Xiao-Yu Guo; Da-Nian Wei; Cheng-Yong Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-06-20

9.  Frontal bone remodeling for gender reassignment of the male forehead: a gender-reassignment surgery.

Authors:  Johannes Franz Hoenig
Journal:  Aesthetic Plast Surg       Date:  2011-05-15       Impact factor: 2.326

10.  Osteogenic properties of PBLG-g-HA/PLLA nanocomposites.

Authors:  Lan Liao; Shuang Yang; Richard J Miron; Junchao Wei; Yufeng Zhang; Meng Zhang
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.